Beyond Broad Topical and Systemic Immunosuppressants: New Research Highlights Advances in Understanding and Treating AD
New research sheds light on the global burden of atopic dermatitis, the most common chronic inflammatory skin disease, affecting more than 200 million individuals worldwide. The research, which is published in the Lancet, also takes a deep dive into novel targeted treatments for AD. Emma Guttman-Yassky, MD, PhD Waldman Professor and System Chair of the […]